Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06747624 · ClinicalTrials.gov registry record · NA

A Crossover Clinical Trial Investigating the Effects of Geranylgeraniol (GG) Supplementation on Testosterone Levels in Healthy Men and Women Over an 18-week Period

A NA study of Health and Wellness, sponsored by Designs for Health.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06747624 is a NA study of Health and Wellness that is active but no longer recruiting, run by Designs for Health. The registered enrollment target is 40 participants, below the 3,281-participant average among 6 other Health trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06747624, a NA study of Health and Wellness, is active but no longer recruiting, sponsored by Designs for Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to investigate the effects of geranylgeraniol (GG) supplementation on testosterone levels in middle-aged (40 to 65 years) healthy men and women. The research team hypothesizes that geranylgeraniol (GG) supplementation will enhance testosterone levels and improve self-reported health outcomes in a healthy population.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Geranylgeraniol 300 mg

Study Locations (1)

Florida

  • Designs for Health, Inc. - Palm Coast

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-01-30
Est. Completion 2025-10
Phase NA

Sponsor

Designs for Health

2 total trials

What the Registry Record Tells You About NCT06747624

The ClinicalTrials.gov registry entry for NCT06747624 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,281-participant average among 6 other Health trials with a reported enrollment target (99% lower). The listed sponsor is Designs for Health, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Health appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06747624 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06747624 about?

NCT06747624 is a clinical study titled "A Crossover Clinical Trial Investigating the Effects of Geranylgeraniol (GG) Supplementation on Testosterone Levels in Healthy Men and Women Over an 18-week Period". The primary purpose of this study is to investigate the effects of geranylgeraniol (GG) supplementation on testosterone levels in middle-aged (40 to 65 years) healthy men and women. The research team hypothesizes that geranylgeraniol (GG) supplementation will enhance testosterone levels and improve...

What is the current status of trial NCT06747624?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-30. Estimated completion is 2025-10.

What conditions does trial NCT06747624 study?

This clinical trial studies the following conditions: Health, Wellness.

What interventions are being tested in trial NCT06747624?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Geranylgeraniol 300 mg (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06747624?

This trial is sponsored by Designs for Health, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06747624 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.